By AIDS Healthcare Foundation Washington D.C. 03-27-2012 FDA has put the interests of drug companies ahead of the health and safety of the American public, says AHF President Michael Weinstein. …
AHF Slams Gilead “HIV Prevention Pill” FDA Application
Despite failed results from numerous clinical trials of Gilead’s HIV/AIDS drug Truvada as an HIV prevention pill (pre-exposure prophylaxis or PrEP), the drug company recently submitted an application to the …
AIDS Healthcare Foundation lobbies against fed PrEP approval
By: SAM SPOKONY, Gay City News New York – August 11, 2011 While medical professionals and advocacy groups have begun to promote the research and development of pre-exposure prophylaxis (PrEP) as a method of HIV prevention …
